These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 129004)

  • 1. Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
    Madden DL; Dietzman DE; Matthew EB; Sever JL; Lander JJ; Purcell RH; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):369-75. PubMed ID: 129004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of serotypes of hepatitis B surface antigen in an institution for the mentally retarded.
    Madden DL; Dietzman DE; Matthew EB; Fuccillo DA; Hall WT; Bond HE; Rostafinski M
    J Infect Dis; 1975 Apr; 131(4):439-42. PubMed ID: 123264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients.
    Hollinger FB; Goyal RK; Hersh T; Powell HC; Schulman RJ; Malnick JL
    Am J Epidemiol; 1972 Apr; 95(4):356-62. PubMed ID: 4259384
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of hepatitis B infection in institutionalized mentally retarded clients.
    Lohiya S; Lohiya G; Caires S
    Am J Public Health; 1986 Jul; 76(7):799-802. PubMed ID: 2940879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].
    Findor JA; Sordá JA; Rey J; Fernández J; Kohan A; Díaz Lestrem M
    G E N; 1992; 46(3):208-12. PubMed ID: 1340826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to hepatitis A antigen in institutionalized mentally retarded patients.
    Szmuness W; Purcell RH; Dienstag JL; Stevens CE
    JAMA; 1977 Apr; 237(16):1702-5. PubMed ID: 139479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of hepatitis B in a residential institution for the mentally retarded.
    Boughton CR; Hawkes RA; Schroeter DR; Harlor JA
    Aust N Z J Med; 1976 Dec; 6(6):521-9. PubMed ID: 139881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Australia (Au-) antigen among patients in a hospital for mentally retarded and its relation to chronic liver disease.
    Nordenfelt E; Andrén-Sandberg M; Lundquist A; Henrikson H
    Scand J Infect Dis; 1971; 3(2):103-7. PubMed ID: 5123800
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded.
    Lehmann NI; Sharma DL; Gust ID
    J Med Virol; 1978; 2(4):335-9. PubMed ID: 215714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Shiono H; Kadowaki J; Fujiwara T; Nakao T
    Clin Pediatr (Phila); 1975 Dec; 14(12):1150-4. PubMed ID: 127683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of hepatitis infection in an institution for the mentally retarded.
    Williamson HG; Lehmann NI; Dimitrakakis M; Sharma DL; Gust ID
    Aust N Z J Med; 1982 Feb; 12(1):30-4. PubMed ID: 6952837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW; Klimek JJ; Upadhyaya A; Devine S
    Am J Infect Control; 1986 Oct; 14(5):204-8. PubMed ID: 3641542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis B markers in patients and staff in a hospital for the mentally handicapped.
    Holt PA; Goodall B; Lees EM; Hambling MH
    J Hosp Infect; 1986 Jan; 7(1):26-33. PubMed ID: 2870105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.